Alesta Therapeutics
PrivateLast Round
Series A
Jan 8, 2025
Total Funding Raised
$67M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alesta Therapeutics is a biotechnology company developing novel oral small molecule therapies for underserved rare diseases such as hypophosphatasia (HPP) and Charcot-Marie-Tooth (CMT).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alesta Therapeutics Comparables
Compare Alesta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Augustine Therapeutics | 78% | |
| ReviR Therapeutics | 72% | |
| BioMarin Pharmaceutical Inc. | 71% | |
Alesta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 8, 2025 |
Alesta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Droia Ventures | Series A |
| Thuja Capital | Series A |
| Frazier Life Sciences | Series A |
| RV Invest | Series A |
| RTW Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 282% MoM, from 263 to 1K.
- May 15, 2026
Monthly visitors increased 105% MoM.
Alesta Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alesta Therapeutics's valuation, stock price, and market status.